Contact
en
CN

World Blood Donor Day|Every Drop of Blood is the Foundation of Innovative Therapies

World Blood Donor Day|Every Drop of Blood is the Foundation of Innovative Therapies
Table of Content [Hide]

    world-blood-donor-dayevery-drop-of-blood-is-the-foundation-of-innovative-therapies.jpg


    June 14 marks the 23rd World Blood Donor Day. This year's global theme is “One Drop of Humanity. Give Blood. Save Lives”, honoring the silent heroes whose voluntary donations safeguard lives worldwide.


    Since the implementation of the Blood Donation Law, China has seen 140 million people participate in voluntary blood donation, with a cumulative total of 308 million donations. The national blood donation rate per 1,000 people has reached 11.4, and China's overall blood safety stands among the highest globally.


    Safe blood is not only essential for routine clinical care, but also serves as the foundation for innovative drug development in cell and gene therapies and rare bleeding disorders. From safety studies of gene therapy products to clinical trials for hemophilia and thrombocytopenia, a reliable blood supply is a prerequisite for advancing research.


    GCP ClinPlus – 23+ years of CRO experience, 2,300+ projects, 200+ MRCTs in China, 220+ approvals. We have built deep expertise in hematology and rare bleeding disorders, recognizing the value of every safe blood donation and remaining committed to advancing innovative therapies through rigorous science and operational excellence.


    Salute to every blood donor and every researcher working for the health of patients.


    https://www.gcpclinplus.com

    global@gcp-clinplus.com


    #WorldBloodDonorDay #BloodDonation #ClinicalTrials #RareBleedingDisorders #BloodSafety #CRO #GCPClinPlus


    References

    CRO Solutions You May Be Interested In

    Latest Articles from GCP ClinPlus

    Radiopharmaceutical Case Study: Pluvicto | From Approval to Access—Why Clinical Results Alone Do Not Determine Value
    China's In Vivo CAR-T Landscape: Technology, Ecosystem, and Clinical Innovation Momentum
    Case Insight | What Does a Deal Worth Up to $1 Billion Reveal About Early CGT Validation?
    2005 Eastpark Blvd., Cranbury, New Jersey, USA, 08540
    Headquarters Address:
    Room 304, Building 508, Lujiatan Street, Puyan Subdistrict, Binjiang District, Hangzhou, Zhejiang, 310051, China
    Tel: +86 400-1006-531
    global@GCP-ClinPlus.com +1 609-2553581
    We use cookies on this site, including third party cookies, to delivery experiennce for you. cookie policy to learn more.
    Reject Accept Cookies